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An important role of NK cells is to eliminate 
cells that extinguish or diminish expression of 
self-MHC class I molecules, which commonly 
occurs as a result of viral infection or cellular 
transformation (Herberman et al., 1975; Kiessling 
et al., 1975; Biron et al., 1999; Diefenbach and 
Raulet, 2002). This capacity arises because NK 
cells express stimulatory and inhibitory receptors 
that engage ligands on normal cells. The major-
ity of inhibitory receptors belong to the KIR (in 
human), Ly49 (in mouse), and CD94/NKG2A 
(both in human and mouse) families and are spe-
cific for MHC I molecules (Raulet et al., 1997; 
Moretta et al., 2001; Lanier, 2005). When an 
NK cell encounters a normal cell, engagement 
of the inhibitory receptors conveys signals that 
counteract stimulatory signaling. Lysis occurs 
when inhibition is lost because the target cell 
lacks one or more self-MHC molecules or when 
target cells express high levels of stimulatory   
ligands that override inhibition (Raulet and 
Vance, 2006).
NK cells vary in the number and specificity 
of MHC-specific inhibitory receptors that they 
express (Raulet et al., 1997). Recent studies 
demonstrate that NK cells vary in basal respon-
siveness  to  stimulatory  receptor  engagement 
depending on the number of expressed inhibi-
tory receptors specific for self-MHC molecules 
(Yu et al., 2007; Brodin et al., 2009; Joncker   
et al., 2009). Cells with several self-MHC– 
specific  receptors  exhibit  the  greatest  basal   
responsiveness and thus mediate the greatest ac-
tivity against target cells that lose MHC. Cells 
with no self-MHC–specific receptors are the 
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Some mature natural killer (NK) cells cannot be inhibited by major histocompatibility 
complex (MHC) I molecules, either because they lack corresponding inhibitory receptors or 
because the host lacks the corresponding MHC I ligands for the receptors. Such NK cells 
nevertheless remain self-tolerant and exhibit a generalized hyporesponsiveness to stimula-
tion through activating receptors. To address whether NK cell responsiveness is set only 
during the NK cell differentiation process, we transferred mature NK cells from wild-type 
(WT) to MHC I–deficient hosts or vice versa. Remarkably, mature responsive NK cells from 
WT mice became hyporesponsive after transfer to MHC I–deficient mice, whereas mature 
hyporesponsive NK cells from MHC I–deficient mice became responsive after transfer to  
WT mice. Altered responsiveness was evident among mature NK cells that had not divided 
in the recipient animals, indicating that the cells were mature before transfer and that 
alterations in activity did not require cell division. Furthermore, the percentages of NK cells 
expressing KLRG1, CD11b, CD27, and Ly49 receptors specific for H-2b were not markedly 
altered after transfer. Thus, the functional activity of mature NK cells can be reset when 
the cells are exposed to a changed MHC environment. These findings have important impli-
cations for how NK cell functions may be curtailed or enhanced in the context of disease.
© 2010 Joncker et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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WT or MHC I–deficient mice, we tested the capacity of the 
mice to reject spleen cell grafts from MHC I–deficient mice 
(Fig. 1 c). Only minimal rejection occurred in irradiated WT 
control mice that did not receive a cell transfer (unpublished 
data). When WT recipients were restored with WT spleen 
most hyporesponsive, to the extent that they fail to attack other-
wise normal cells lacking MHC molecules. These data sug-
gest that the responsiveness set point of individual NK cells is 
tuned depending on the balance of inhibitory and stimulatory 
ligands that each NK cell encounters on neighboring cells in 
the normal environment (Joncker and Raulet, 2008).
An important unanswered question is whether the basal 
responsiveness of NK cells is set only once during NK cell de-
velopment or, alternatively, can be readjusted when the fully 
mature NK cell is exposed to a changing MHC environment. 
Readjustments of NK cell responsiveness, if they occur, may 
account for instances under which NK cells fail to eliminate 
tumors or pathogen-infected cells and will be important to ad-
dress when testing therapies designed to augment or suppress 
NK cell activity in the context of disease.
RESULTS AND DISCUSSION
Splenic NK cells reset their functional potential downward 
when transferred to MHC I–deficient mice
We used an adoptive transfer system to test whether the re-
sponsiveness of NK cells can be reset after the NK cells reach 
maturity. Splenocytes from C57BL/6 mice, containing a ma-
jority of responsive NK cells (Fernandez et al., 2005; Joncker 
et al., 2009), were transferred to irradiated congenic MHC I–
deficient or control WT mice, and responsiveness was tested 
10 d later. To test responsiveness, splenocytes from the recip-
ients were stimulated in vitro with plate-bound antibodies   
specific for the stimulatory receptors NKG2D or NKR-P1C. 
Intracellular IFN- production by donor NK cells was deter-
mined by gating on the congenic CD45 marker. The results 
demonstrated a striking hyporesponsiveness of WT NK cells 
to NKG2D and NKR-P1C stimulation after transfer to 
MHC I–deficient hosts, comparable with that of MHC I– 
deficient NK cells after transfer to MHC I–deficient hosts 
(Fig. 1 a). Hyporesponsiveness arose from exposure to the 
MHC-deficient environment because the same NK cells 
transferred to WT mice exhibited strong responsiveness   
(Fig. 1 a and not depicted). Time course experiments dem-
onstrated that some resetting occurred as little as 4 d after 
transfer but required at least 7–10 d to be fully established 
(unpublished data).
In WT B6 mice, the responsive NK cells express one or 
more of the three receptors that bind appreciably to H-2b 
class  I  molecules,  Ly49C,  Ly49I,  and/or  CD94/NKG2A 
(CIN+ NK cells; Fernandez et al., 2005; Joncker et al., 2009). 
NK cells lacking these three receptors (CIN NK cells) are 
largely hyporesponsive in B6 mice. The alterations in NK 
cell responsiveness after transfer occurred for the most part   
in the CIN+ NK cell population, as expected (Fig. 1 b). The 
CIN population was relatively hyporesponsive after transfer 
in all combinations tested, and the differences in CIN cells 
responsiveness were neither statistically significant nor repro-
ducible (unpublished data).
Resetting of NK cell function after transfer to MHC I–
deficient mice was also evident in an in vivo assay of NK cell 
function. 12 d after transfer of WT splenocytes to irradiated 
Figure 1.  Responsive NK cells reset their functional potential 
downward in the absence of MHC I contact. Responses of WT NK cells 
after transfer to WT or 2m-deficient hosts. (a and b) 10 d after transfer, 
splenic NK cells were stimulated for 5 h with 5 µg/ml of plate-bound 
NKG2D or 50 µg/ml NKR-P1C antibody as indicated. The percentage of 
IFN-–producing NK cells among gated donor NK cells (a) or gated donor 
NK cells expressing one or more of Ly49C, Ly49I, and/or CD94/NKG2A 
(CIN+) or lacking those three receptors (CIN; b) was determined by flow 
cytometry. Responses of NK cells from unmanipulated WT and 2m/ 
mice are shown for comparison. Experiments were repeated five to six 
times with n = 3–5 each for transfer groups. For relevant comparisons, 
statistical significance was determined with a two-tailed unpaired (a) or 
paired (b) Student’s t test (*, P < 0.05; ***, P < 0.0005). ctrls, controls. (c) At 
day 12 after transfer, groups of adoptive transfer recipients (n = 3–4) 
received grafts of CFSEhigh-labeled 2m/ spleen cells mixed with an 
equal number of CFSElow-labeled WT spleen cells. Rejection of 2m/ 
target cells was determined by flow cytometry of spleen cells 18 h later. 
Some groups of transfer recipients were pretreated i.p. twice (on days 2 
and 1 relative to the time of engraftment) with 200 µg PK136 (NK1.1) 
antibody to deplete NK cells, as indicated. The experiment was repeated 
three times with n = 3–6 mice for each (***, P = 0.0002). Data represent 
means ± SEM.JEM VOL. 207, September 27, 2010  2067
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this analysis, donor spleen cells were labeled with CFSE be-
fore transfer, and the extent of CFSE dilution was assessed in 
NK cells harvested 10 d after transfer. A significant fraction of 
NK cells (between 10 and 30% in different experiments) had 
not divided 10 d after transfer (unpublished data). By gating 
on NK cells that had not divided after transfer, we observed 
the same patterns of responsiveness that we had observed in 
the bulk populations: WT (or MHC I deficient) NK cells 
transferred to MHC I–deficient hosts exhibited relatively low 
responsiveness (Fig. 3 a), whereas MHC I–deficient (or WT) 
cells, strong rejection occurred. The rejection was mediated 
by NK cells, as shown by depleting NK cells before engraft-
ment. In contrast, MHC I–deficient recipients that were re-
stored with WT NK cells failed to reject MHC I–deficient 
grafts. An absence of NK cells could not account for the fail-
ure to reject the grafts because these recipients contained as 
many donor NK cells as did WT recipients of WT NK cells 
(unpublished data).
Hyporesponsive NK cells reset their functional potential 
upwards when exposed to MHC I+ cells
Having found that exposure of WT NK cells to an MHC I–
deficient environment renders the NK cell population hypo-
responsive,  we  asked  whether  the  reverse  was  true,  i.e., 
whether exposure of MHC I–deficient NK cells to an MHC I+ 
environment increases the responsiveness of the NK cells. 
MHC I–deficient splenocytes could not be transferred into 
WT hosts because the host’s NK cells rejected the donor 
cells. Therefore, we used an NK cell–deficient strain (NKD 
mice; Kim et al., 2000) as recipients. When MHC I–deficient 
splenocytes were transferred to irradiated NKD (MHC I+) 
mice for 10 d, the responsiveness of the NK cells was signifi-
cantly enhanced compared with the responsiveness of the 
same NK cells after transfer to MHC I–deficient hosts (Fig. 2). 
In some repetitions, the response approached the level ob-
served in WT mice (Fig. 2 a), and in others, it was intermedi-
ate between WT and MHC I deficient (Fig. 2 b). Similar 
results were obtained whether the adoptive transfer hosts were 
pretreated with polyinosinic-polycytidylic acid (Poly I:C)   
for 36 h to enhance NK activity (Fig. 2, b and c) or were tested 
without pretreatment (Fig. 2 a). The increase in respon-
siveness after transfer to NKD mice was most pronounced 
in the CIN+ population, whereas the CIN population was 
by comparison relatively hyporesponsive (Fig. 2 c). Collec-
tively, the data indicate that the responsiveness of peripheral 
NK cells can be reset both downward and upward depending 
on the steady-state MHC environment to which the NK 
cells are exposed.
Resetting occurs in mature NK cells
A shorter transfer time of 4 d revealed similar trends in terms 
of both upward and downward resetting of NK activity, but 
the differences were not statistically significant, suggesting 
that >4 d are required for maximal resetting (unpublished 
data). Although we would not expect extensive NK differen-
tiation from stem cells to occur in ≤10 d, it remained possible 
that  the  changes  in  activity  we  observed  after  transfer  of 
spleen cells applied only to new NK cells that differentiated 
in the adoptive host from donor hematopoietic precursor 
cells. If this occurred, the new results would not speak to 
whether the MHC environment influences the activity of 
mature (as opposed to differentiating) NK cells. To distin-
guish NK cells that were already mature at the time of trans-
fer from NK cells that differentiated after transfer, we took 
advantage of the knowledge that NK cell differentiation in-
volves extensive cellular proliferation (Kim et al., 2002). For 
Figure 2.  Hyporesponsive NK cells reset their functional potential 
upwards when exposed to MHC I–expressing cells. (a–c) Responses of 
2m/ NK cells after transfer to MHC I–expressing NK cell–deficient 
(NKD) or 2m-deficient hosts. Stimulations and assays were performed as 
in Fig. 1. The percentage of IFN-–producing NK cells among gated donor 
NK cells (a and b) or gated donor CIN+ and CIN NK cells (c) was deter-
mined by flow cytometry. Recipients were either left untreated (a) or 
treated with Poly I:C (b and c) 36 h before in vitro stimulation to augment 
the responses. Experiments were repeated four times with n = 3–6 mice 
each for transfer groups. For relevant comparisons, statistical significance 
was determined with a two-tailed unpaired (a and b) or paired (c) Stu-
dent’s t test (*, P < 0.05; **, P < 0.005; ***, P < 0.0005). Data represent 
means ± SEM. ctrls, controls.2068 Resetting NK cell responsiveness | Joncker et al.
which were shown, using in vitro experiments, to be ampli-
fied after challenge with MHC I+ cells (Glas et al., 1994). 
However, we determined that it was necessary to deplete the 
hosts of both CD8+ and CD4+ T cells before transfer to pre-
vent rejection of MHC I+ cells (unpublished data), possibly 
reflecting the action of MHC I–specific antibodies in the re-
jection process. Therefore, in the subsequent experiments, the 
hosts were depleted of both CD8+ and CD4+ T cells before 
transfer and the cells were parked for a slightly shorter time 
period before analysis. WT cells transferred to unirradiated 
MHC  I–deficient  mice  were  rendered  hyporesponsive  to 
NKG2D stimulation, similar to our findings in irradiated mice 
(Fig. 3 c). In unirradiated hosts, the donor NK cells under-
went little or no homeostatic proliferation, as expected   
(unpublished data). Thus, downward resetting does not de-
pend on the use of irradiated hosts. We were unable to per-
form the converse experiment (upward resetting after transfer 
of MHC I–deficient cells to unirradiated WT mice) because 
of rejection of donor cells by residual NK cells in unirradiated 
NKD mice.
NK subset composition after transfer
To determine whether functional resetting correlated with 
changes in subset composition after transfer, we determined 
the phenotypes of gated CFSEhigh NK cells, which we infer 
correspond to transferred NK cells rather than NK cells that 
differentiated from precursor cells after transfer. Because CIN+ 
and CIN NK cells correspond to responsive and hypore-
sponsive NK cells in normal B6 mice (Fernandez et al., 2005), 
we  determined  whether  the  proportions  of  these  subsets 
changed after transfer. Analysis showed that the proportions of 
CIN+ and CIN NK cells among total NK cells or among 
those that did not divide after transfer did not change signifi-
cantly in the various transfer combinations (Fig. 4 a). As   
already emphasized, the changes in responsiveness after trans-
fer can be accounted for by changes in the responsiveness of 
CIN+ NK cells after transfer (Figs. 1 and 2).
KLRG1  is  expressed  by  more  WT  than  2-micro-
globulin/ (2m/) NK cells and by more CIN+ than CIN 
NK cells in WT mice (Corral et al., 2000; Fernandez et al., 
2005) and thus correlates with the responsive subset. Direct 
assays confirmed that in normal B6 mice, KLRG1high NK 
cells reproducibly responded better to antireceptor antibod-
ies than KLRG1low NK cells (Fig. 4 b). Interestingly, WT 
NK  cells  that  had  been  transferred  to  MHC  I–deficient 
hosts exhibited a modestly reduced percentage of KLRG1high 
NK cells, compared with WT NK cells that had been trans-
ferred to WT hosts (Fig. 4 c). Conversely, MHC I–deficient 
NK  cells  that  had  been  transferred  to  MHC  I+  hosts   
exhibited a modestly increased percentage of KLRG1high  
NK cells compared with MHC I–deficient NK cells recov-
ered from MHC I–deficient hosts. However, these differ-
ences were small compared with the functional differences 
we observed (Figs. 1 and 2), suggesting that resetting results 
in changes in both the composition of NK subsets and their 
functional activity.
NK cells transferred to MHC I+ hosts exhibited elevated re-
sponsiveness (Fig. 3 b). These data argue that the changes in 
NK responsiveness after transfer occur in nondividing mature 
NK cells, as opposed to representing the activity of newly dif-
ferentiated NK cells that arose after transfer. In general, NK 
cells in all groups that had undergone several divisions exhib-
ited lower activity, suggesting that many of them corresponded 
to NK cells that differentiated after transfer from precursor 
cells but had yet to attain full maturity (Fig. 3).
The experiments to this point were performed in irradi-
ated hosts, so an additional analysis was performed to deter-
mine whether downward NK cell resetting occurs after 
transfer to unirradiated hosts. Preliminary experiments showed 
that unirradiated MHC I–deficient hosts reject WT hemato-
poietic cells (unpublished data). The rejection was likely 
caused in part by the action of rare CD8+ CTLs in such hosts, 
Figure 3.  Functional resetting occurs even in NK cells that do not 
divide after transfer. (a) CFSE-labeled WT splenocytes were transferred 
to irradiated WT or 2m-deficient hosts. (b) CFSE-labeled 2m/ spleno-
cytes were transferred to irradiated 2m/ or MHC I–expressing NK cell–
deficient (NKD) hosts. 10 d after transfer, NK cells were stimulated and 
assayed as in Fig. 1, except that the donor cells were gated based on CFSE 
level, distinguishing cells that had divided 0, 1, 2, 3, or 4 times after initial 
labeling. Experiments were repeated two to four times with n = 3–6 mice 
for each. (c) WT splenocytes were transferred to unirradiated, CD8a- and 
CD4-depleted WT, or 2m-deficient hosts. 9 d after transfer, NK cells  
were stimulated and assayed as in Fig. 1. The experiment was performed 
twice with n = 3–5 mice. For some comparisons, statistical significance 
was determined with a two-tailed unpaired Student’s t test (*, P < 0.05;  
**, P < 0.005; ***, P < 0.0005). Data represent means ± SEM.JEM VOL. 207, September 27, 2010  2069
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from the mice be-
fore transfer. In con-
trast, the grafts were 
accepted by chime-
ras in which either 
the host or transferred fetal liver cells contained MHC I– 
deficient cells, including the [(+) into ()], [() into (+)], 
[(+) into ()], [(mix) into (+)], and [(mix) into ()] chimeras. 
The outcome was the same whether the MHC I–deficient 
cells used to test graft rejection were spleen cells or bone mar-
row cells and whether the hosts were reirradiated or not be-
fore applying the test grafts (Fig. 5 b). Analysis showed that the 
chimeras were generally reconstituted with >95% donor cells 
and that the mixed chimeras contained between 25 and 50% 
of donor 2m/ cells at the time of assay (unpublished data). 
Collectively,  these  data  indicate  that  developing  NK  cells 
were rendered tolerant to MHC I–deficient cells when the 
NK cells developed in an environment containing MHC I– 
deficient cells. Tolerance occurred similarly whether the 
MHC I–deficient cells were derived from radioresistant host 
cells or donor fetal liver cells.
Concluding remarks
Our results indicate that the responsiveness of NK cells re-
mains plastic once the cells reach maturity and can be reset 
when the cells are exposed to an environment in which MHC 
expression differs. Resetting was not dependent on NK cell 
proliferation. Of note, the results contrast with the finding 
that sustained blockade of inhibitory receptors in vivo with 
mAb failed to render NK cells hyporesponsive (Sola et al., 
2009; Vahlne et al., 2010). The discrepancy may reflect diffi-
culties in maintaining complete blockade of the inhibitory re-
ceptors under these conditions.
In the chimera experiments, donor MHC I–deficient cells 
induced tolerance to MHC I–deficient cells (e.g., in [() into 
(+)] or [(mix) into (+)] chimeras), whereas in the () into (+) 
Expression of the CD11b and CD27 markers define four 
NK  subsets,  labeled  R0  (CD27  CD11b),  R1  (CD27+ 
CD11b), R2 (CD27+ CD11b+), and R3 (CD27 CD11b+). 
The R3 population includes somewhat higher percentages   
of Ly49+ and KLRG1high NK cells and greater expression of 
genes  involved  in  NK  effector  functions  (Hayakawa  and 
Smyth, 2006; Chiossone et al., 2009; unpublished data). Con-
sistent with these features, but in contrast to the findings of 
others (Hayakawa and Smyth, 2006), we consistently observed 
that R3 NK cells were more responsive than R2 NK cells, or 
in some cases roughly equal in responsiveness (Fig. 4 d and 
not depicted). R1 and R0 cells showed substantially less func-
tional activity. Although there were modest changes in the 
percentages of R2 and R3 cells when comparing the various 
transfer combinations, the changes did not provide an ade-
quate explanation for the functional differences we observed 
(Fig. 4 e).
The responsiveness of developing NK cells is determined  
by the MHC environment in which they mature
A previous study showed that in stable chimeras in which WT 
and MHC I–deficient fetal liver precursors codeveloped into 
NK cells in the same animal, the resulting NK cells were im-
paired in rejecting MHC I–deficient bone marrow grafts (Wu 
and  Raulet,  1997).  Because  those  experiments  were  per-
formed with methods that are currently little used, we have 
repeated these experiments using a modern assay to confirm 
and extend the results. Fetal liver chimeras were prepared 
combining MHC I+ and/or MHC I–deficient fetal liver cells 
and hosts in various combinations (Fig. 5 a). After allowing 
between 9 and 19 wk for reconstitution, we tested NK func-
tion in vivo by determining whether the chimeras could reject 
spleen cell or bone marrow grafts from MHC I–deficient 
mice (Fig. 5 b). MHC I+ hosts reconstituted with MHC I+ 
fetal liver cells ([(+) into (+)] chimeras) rejected the grafts, and 
the rejection was prevented when NK cells were depleted 
Figure 4.  Phenotypic changes associated 
with resetting. (a) 10 d after transfer of 
CFSE-labeled splenocytes, the frequencies of 
CIN+ and CIN NK cells were determined 
among gated donor NK cells that remained 
undivided after transfer by staining with 
Ly49C, Ly49I, and NKG2A antibodies. (b) IFN- 
response of KLRG1high and KLRG1low WT NK 
cells to stimulation with 5 µg/ml plate-bound 
NKG2D antibody. (c) Percentages of KLRG1high 
cells among undivided donor NK cells at day 
10 after transfer. (d) IFN- response of CD27 
CD11b, CD27+ CD11b, CD27+ CD11b+, and 
CD27 CD11b+ NK cell subsets from WT mice 
upon stimulation with 5 µg/ml anti-NKG2D. 
(e) Distribution of undivided donor NK cells 
among the CD27/CD11b-defined subsets at 
day 10 after transfer. Asterisks indicate a sta-
tistically significant difference as calculated 
by two-tailed paired (b) or unpaired (c) Stu-
dent’s t test (*, P < 0.05; ***, P < 0.0005).  
Experiments were performed two to four 
times with n = 3–6 mice, except one repeat  
of panel d where n = 2 mice. Data represent 
means ± SEM.2070 Resetting NK cell responsiveness | Joncker et al.
or, alternatively, represent a specialized subset of hematopoi-
etic cells.
In the adoptive transfers, and in some combinations of the 
chimeras, the responsiveness of donor NK cells was deter-
mined by whether the recipient cells expressed MHC I or not, 
indicating that trans interactions between NK cell inhibitory 
receptors and MHC molecules on other cells played an impor-
tant role in determining the responsiveness of NK cells. It re-
mains  possible  that  cis  interactions  between  the  inhibitory 
receptors and MHC molecules in the same NK cell play a   
role in determining NK responsiveness in other contexts 
(Chalifour et al., 2009). Indeed, it is possible that two or more 
independent mechanisms based on different types of interac-
tions, and possibly operative at different stages of the NK cell 
lifecycle (developing vs. mature cells), work in parallel to en-
sure NK cell hyporesponsiveness.
Although not addressed in this study, it is plausible that the 
resetting of NK responsiveness also occurs in cases in which 
NK cells are exposed to cells with reduced expression of other 
inhibitory ligands or increased expression of stimulatory   
ligands. NK cell responsiveness may also be altered by other 
environmental cues such as those that accompany infections. 
For example, an early study showed that Listeria monocytogenes 
infections of mice cause hyporesponsive NK cells to produce 
similar amounts of IFN- to responsive NK cells (Fernandez 
et  al.,  2005).  Furthermore,  hyporesponsive  Ly49C/I  
NK cells respond even better than Ly49C/I+ NK cells in   
cytomegalovirus-infected mice (Orr et al., 2010). Finally, Sun 
and Lanier (2008) showed that mouse cytomegalovirus infection 
caused a rapid rejection of MHC I–deficient donor cells in 
[(mix) into (+)] chimeras.
We propose that the capacity of NK cells to reset their 
responsiveness represents a mechanism to set the triggering 
threshold of NK cells to an appropriate level under normal 
conditions, to prevent autoreactivity, while preserving op-
timal reactivity to MHC I–deficient or other stimulatory 
target cells. The results have important implications for un-
derstanding NK cell functions in the context of disease. 
First, the downward resetting of NK cell activity that oc-
curs after transfer to MHC I–deficient mice provides one 
plausible explanation for how NK cells become inactivated 
in certain tumors. Multiple studies have identified NK cells 
in  tumor-bearing  patients  that  are  anergic  or  incapable   
of attacking the tumor cells (Costello et al., 2002; Epling-
Burnette et al., 2007). NK cells that are exposed to tumor 
cells, which frequently extinguish MHC I molecules, may 
initially lyse the tumor cells, but persistent exposure may 
cause the NK cells to adopt a hyporesponsive state. Con-
versely, although NK cells may protect against autoimmu-
nity in some cases (Lünemann et al., 2009), they reportedly 
contribute to the development of autoimmunity in others 
(Poirot et al., 2004; Feuerer et al., 2009; Lünemann et al., 
2009); the potential for NK cells to reset their responsive-
ness upwards in a changing environment could play a role 
in promoting autoimmunity in these instances. A deeper 
understanding  of  the  signals  that  mediate  these  different 
adoptive transfers, the NK cells were converted to high re-
sponsiveness. The two results may reflect the different assays 
used, but another possibility is that in the chimeras, a specific 
population of donor MHC I–deficient stromal cell precursors 
eventually seeded and repopulated niches in the bone mar-
row or elsewhere. The donor stromal cells may be specialized 
for inducing NK cell hyporesponsiveness and/or responsive-
ness. Donor cell repopulation of stromal niches may not   
occur in the adoptive transfers either because of the short   
duration of the transfers or because the relevant cells are rare 
or absent in the spleen compared with the fetal liver. A domi-
nant role of stromal cells in resetting was consistent with the 
observation that MHC expression, or not, by donor lympho-
hematopoietic cells in the resetting experiments had little   
or no impact on the ultimate responsiveness of cotrans-
ferred NK cells (Figs. 1–3). The relevant stromal cells may be 
nonhematopoietic in origin (although present in fetal liver) 
Figure 5.  The responsiveness of developing NK cells is set depend-
ing on the MHC environment in which they mature. (a) Experimental 
scheme for producing mixed fetal liver cell chimeras and testing rejection 
of MHC I–deficient cells. WT (+), 2m/ (), or a 1:1 mix of WT and 
2m/ (mix) fetal liver cells was used to reconstitute lethally irradiated 
and NK-depleted hosts. (b) After 9–17 wk of reconstitution, chimeras 
were reirradiated or not before testing whether the chimeras rejected 
2m/ spleen cells or bone marrow cells, as indicated. Unmanipulated 
B6 and 2m/ mice were tested in parallel as controls for rejection and 
tolerance, respectively. The rejection assay was performed by injecting 
CFSEhigh-labeled 2m/ cells (spleen or bone marrow) mixed with an 
equal number of CFSElow-labeled WT spleen cells as an internal control. 
Rejection of 2m/ spleen cells was determined by flow cytometry of 
spleen cells 18 h later. Some groups of chimeras were pretreated i.p. twice 
(on days 2 and 1) with 200 µg PK136 (NK1.1) antibody (NK depleted), 
as indicated. Data represent means ± SEM (n = 2–5 mice). The experiment 
was performed three times with spleen cell targets and once with bone 
marrow cell targets. nd, not done.JEM VOL. 207, September 27, 2010  2071
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reject class I–deficient grafts (Bix et al., 1991). Relative 2m/ graft accep-
tance (Fig. 5 b) was calculated as the ratio of 2m/ to B6 cells among 
CFSE+ recipient spleen cells.
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outcomes will aid in determining the role of resetting in the 
genesis and prevention of inflammatory disease, malignancy, 
and infectious disease.
MATERIALS AND METHODS
Mice and adoptive transfers. Mice were bred at the University of Cali-
fornia,  Berkeley,  from  breeders  obtained  from  The  Jackson  Laboratory 
(C57BL/6J, designated B6 or WT), Charles River (B6-Ly5.2/Cr, which ex-
press Ly5.1), or W. Yokoyama (Washington University in St. Louis, St. Louis, 
MO; NKD mice). 2m/ mice on the B6 background were described previ-
ously (Zijlstra et al., 1989). B6 2m/–Ly5.1 mice were bred in our facilities. 
WT or 2m/ splenocytes were injected i.v. in hosts that had received 6 Gy 
of irradiation from a 137Cs source 4–5 h earlier. For adoptive transfers in un-
irradiated mice, recipients were treated i.p. with 200 µg of depleting CD8a and 
CD4 antibodies the day before transfer and at days 1, 4, and 7 after transfer. 
Each host received 108 donor splenocytes corresponding to 2.5–3.5 × 106 NK 
cells. Where indicated, donor NK cells were labeled with CFSE (Invitrogen) 
before transfer. Animal protocols were approved by the Animal Care and Use 
Committee at the University of California, Berkeley, and animals were main-
tained in accordance with the guidelines of the National Institutes of Health.
Radiation chimeras. Fetal liver chimeras were prepared as described in Wu 
and Raulet (1997). The recipients received 9.5 Gy for 5 h before injection 
with 107 liver cells from embryonic day 14–17 donors or 107 of each type for 
mixed chimeras. WT recipients of MHC I–deficient fetal liver cells were pre-
treated with 200 µg PK136 antibody 1 and 2 d before irradiation of the mice.
Antibodies  and  flow  cytometry  analysis.  Antibodies  against  NK1.1 
(PK136), CD3- (145-2C11), NKG2A/C/E (20d5), Ly49I (YLI-90), CD45.1 
(A20), CD45.2 (104), IFN- (XMG1.2), NKG2D (MI6; Jamieson et al., 
2002),  NKp46  (29A1.4),  KLRG1  (2F1),  CD27  (LG.3A10),  and  CD11b 
(M1/70) were purchased from eBioscience and BD. Ly49C antibody 4LO3311 
(a gift from S. Lemieux, l’Institut national de la recherche scientifique–Institut 
Armand-Frappier, Laval, Québec, Canada; Gosselin et al., 1997) was purified 
and conjugated to biotin according to standard methods. Biotin-conjugated 
mAbs were detected with streptavidin Pacific blue (Invitrogen). Depleting 
NK1.1 antibody (PK136) was purified from CELLine classical 1000 superna-
tants (Integra Biosciences). Depleting CD8a (2.43) and CD4 (GK1.5) antibod-
ies were purchased from Bio X Cell. Before staining, cells were preincubated 
for 20 min with 2.4G2 hybridoma supernatant to block FcRII/III receptors. 
Flow cytometry was performed on a cytometer (LSR II; BD), and data were 
analyzed with the FlowJo software (Tree Star, Inc.).
In vitro NK cell stimulation and IFN- assay. As previously described 
(Joncker et al., 2009), flat-bottomed, high protein-binding plates (Thermo 
Fisher Scientific) were coated with NKG2D or NKR-P1C antibodies, and 
NK cells (106 spleen cells per well) were stimulated therein for 5 h in the   
presence of 1 µg/ml GolgiPlug (BD) and 1,000 U/ml recombinant human 
IL-2 (Roche) before staining the cells for intracellular IFN- accumulation.   
In some experiments, as indicated, mice were injected i.p. with 200 µg Poly I:C 
(Sigma-Aldrich) 1.5 d before harvesting spleens.
CFSE-labeled  spleen  and  bone  marrow  cell  engraftment  assay. 
Spleen and bone marrow graft rejection assays were performed as previously 
described (Joncker et al., 2009). Spleen or bone marrow cells from Ly5 con-
genic 2m/ were labeled with 10 µM CFSE (CFSEhigh), and correspond-
ing B6 cells were labeled with 1 µM CFSE (CFSElow) for 10 min at 37°C. 
The two types of cells were mixed 1:1 and injected (5 × 106 each) i.v. into 
mice that had been irradiated, or not, as indicated, earlier in the day with 9.5 Gy. 
Some mice were predepleted of NK cells by two i.p. injections of 200 µg 
PK136 (anti-NK1.1). Recipient spleens cells, harvested 18 h after transplan-
tation, were analyzed for CFSE+ congenic MHC I–deficient and control B6 
cells based on the intensity of CFSE staining. Percent graft rejection (Fig. 1 c) 
was defined as 100 × (1  [%2m/ cells/%B6 cells]) among CFSE+ recipient 
spleen cells, after normalizing to the mean corresponding rejection obtained 
when the same cells were injected into 2m/ recipients, which cannot   2072 Resetting NK cell responsiveness | Joncker et al.
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